Literature DB >> 9324129

Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma.

T J Howard1, A C Chin, E W Streib, K K Kopecky, E A Wiebke.   

Abstract

BACKGROUND: High-quality preoperative radiographic evaluation is crucial in selecting patients with periampullary carcinomas who are candidates for surgical exploration and tumor resection while minimizing the rate of unnecessary laparotomy.
METHODS: Twenty-one consecutive patients were prospectively investigated using helical computed tomography (CT) scanning, endoscopic ultrasonography (EUS), and selective visceral angiography (SVA) to determine tumor resectability. All patients were explored and resectability determined.
RESULTS: Helical CT had a sensitivity of 63%, a specificity of 100%, and an overall accuracy of 86%. EUS had a sensitivity of 75%, a specificity of 77%, and an overall accuracy of 76%. SVA had a sensitivity of 38%, a specificity of 92%, and an overall accuracy of 71%.
CONCLUSIONS: Helical CT scanning is the best preoperative imaging test to determine tumor resectability. EUS is more sensitive than CT for tumor detection, but underestimates resectability. SVA is no longer helpful in the preoperative evaluation of these malignancies.

Entities:  

Mesh:

Year:  1997        PMID: 9324129     DOI: 10.1016/s0002-9610(97)00132-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  21 in total

Review 1.  Endoscopic ultrasonography: imaging and beyond.

Authors:  T Rösch
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 2.  Imaging for the diagnosis and staging of periampullary carcinomas.

Authors:  R M Walsh; M Connelly; M Baker
Journal:  Surg Endosc       Date:  2003-08-15       Impact factor: 4.584

3.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  New approach to diagnosing ampullary tumors by magnifying endoscopy combined with a narrow-band imaging system.

Authors:  Yujiro Uchiyama; Hiroo Imazu; Hiroshi Kakutani; Shoryoku Hino; Kazuki Sumiyama; Akira Kuramochi; Shintaro Tsukinaga; Kazuhiro Matsunaga; Takashi Nakayoshi; Ken-ichi Goda; Shoichi Saito; Mitsuru Kaise; Muneo Kawamuara; Salem Omar; Hisao Tajiri
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

Review 5.  The investigation of unexplained biliary dilatation.

Authors:  Alan Coss; Robert Enns
Journal:  Curr Gastroenterol Rep       Date:  2009-04

Review 6.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

Review 7.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

8.  Performance characteristics of endoscopic ultrasound in the staging of pancreatic cancer: a meta-analysis.

Authors:  Haq Nawaz; Chen Yi Fan; John Kloke; Asif Khalid; Kevin McGrath; Douglas Landsittel; Georgios I Papachristou
Journal:  JOP       Date:  2013-09-10

9.  The value of imaging techniques in the staging of pancreatic cancer.

Authors:  J Kulig; T Popiela; A Zajac; S Kłek; P Kołodziejczyk
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

10.  Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.

Authors:  Kaitlyn J Kelly; Joyce Wong; Rebecca Gladdy; Kimberly Moore-Dalal; Yanghee Woo; Mithat Gonen; Murray Brennan; Peter Allen; Yuman Fong; Daniel Coit
Journal:  Ann Surg Oncol       Date:  2009-09-18       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.